MINICAP WITH POVIDONE-IODINE SOLUTION - This device is a plastic disconnect cap for - BAXTER HEALTHCARE CORPORATION

Duns Number:005083209

Device Description: This device is a plastic disconnect cap for peritoneal dialysis and contains povidone-iodi This device is a plastic disconnect cap for peritoneal dialysis and contains povidone-iodine intended to protect the female Luer connector of the Baxter transfer set.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

5C4466P

Brand Name

MINICAP WITH POVIDONE-IODINE SOLUTION

Version/Model Number

5C4466P

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

KDJ

Product Code Name

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

Device Record Status

Public Device Record Key

d6c3779b-8d07-48c9-ac63-4369f68ce95b

Public Version Date

November 23, 2020

Public Version Number

4

DI Record Publish Date

October 07, 2015

Additional Identifiers

Package DI Number

50085412007699

Quantity per Package

60

Contains DI Package

00085412007694

Package Discontinue Date

-

Package Status

In Commercial Distribution

Package Type

CASE

"BAXTER HEALTHCARE CORPORATION" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 16
2 A medical device with a moderate to high risk that requires special controls. 101
3 A medical device with high risk that requires premarket approval 19